Skip to content
Valuesider
Guess what? Valuesider just got better: smarter and more intuitive.
Novo Nordisk A/S

NVO

Novo Nordisk A/S

Novo Nordisk A/S 13F Holders

NVO Stock Ownership Activity

# of activities:
2
AVG reported price*:
$69.44
Current price*:
-29.51%($48.94)
2 value investing gurus have made changes to the Novo Nordisk A/S (NVO) position according to the gurus' 2025 Q1 SEC quarterly report(s). The number of NVO shares has been increased by 1, decreased by 1 super investor(s).

Which gurus or hedge funds bought NVO in 2025 Q1?

According to the 2025 Q1 SEC filing(s) Novo Nordisk A/S (NVO) has been bought by Parnassus Endeavor Fund (added shares +55.98%).
To see more about who is investing in Novo Nordisk A/S (NVO), please go to the NVO ownership page.
2 results
History Name Company % or
activity 		Shares
change 		Shares
held after* 		% change
to portfolio 		% of
portfolio 		Held since* Held for*
Parnassus Investments
Parnassus Endeavor Fund
+55.98%
+332,361
926,083
+0.52%
1.44%
2024 Q4
≈ 0.50 years
David M. Polen
Polen Capital Management
-84.36%
-5,403,842
1,001,906
-1.01%
0.22%
2023 Q3
≈ 1.75 years
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.